KAREN CALLAHAN: Open Payments
NPI 1154371508 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 21 payments from 5 companies in 2025. Trend: 2023 $629 · 2024 $453 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $164 |
| Lundbeck LLC | 2 | $64 |
| Neurocrine BioSciences, Inc. | 1 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Brainsway USA INC | 1 | $15 |
Products named: VRAYLAR, REXULTI, INGREZZA, Deep TMS System.
Industry payments across AL — which companies pay providers there.
